Evidence map›Paper›PMID 36057383›Full record

ArticleThe Journal of infection2022

Remdesivir reduced upper respiratory tract SARS-CoV-2 viral RNA concentration in COVID-19 patients who developed pneumonitis.

Christopher Kc Lai, Grace Cy Lui, Yuchen Wei, Ka Chun Chong, Zigui Chen, Lowell Ling, Rita Wy Ng, Siaw Ss Boon, Wendy Cs Ho, Apple Cm Yeung and 2 more

Open access · bronzeAbstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 1 institution in 2 countries.

Christopher Kc LaiDepartment of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, 1/F, Clinical Sciences Building, Prince of Wales Hospital, 30-32 Ngan Shing Street, N.T., Shatin, China Hong Kong Special Administrative Region.
Grace Cy LuiDepartment of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, China Hong Kong Special Administrative Region; Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, China Hong Kong Special Administrative Region.
Yuchen WeiSchool of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, China Hong Kong Special Administrative Region.
Ka Chun ChongSchool of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, China Hong Kong Special Administrative Region.
Zigui ChenDepartment of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, 1/F, Clinical Sciences Building, Prince of Wales Hospital, 30-32 Ngan Shing Street, N.T., Shatin, China Hong Kong Special Administrative Region.
Lowell LingDepartment of Anaesthesia and Intensive Care, Faculty of Medicine of Medicine, The Chinese University of Hong Kong, China Hong Kong Special Administrative Region.
Rita Wy NgDepartment of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, 1/F, Clinical Sciences Building, Prince of Wales Hospital, 30-32 Ngan Shing Street, N.T., Shatin, China Hong Kong Special Administrative Region.
Siaw Ss BoonDepartment of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, 1/F, Clinical Sciences Building, Prince of Wales Hospital, 30-32 Ngan Shing Street, N.T., Shatin, China Hong Kong Special Administrative Region.
Wendy Cs HoDepartment of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, 1/F, Clinical Sciences Building, Prince of Wales Hospital, 30-32 Ngan Shing Street, N.T., Shatin, China Hong Kong Special Administrative Region.
Apple Cm YeungDepartment of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, 1/F, Clinical Sciences Building, Prince of Wales Hospital, 30-32 Ngan Shing Street, N.T., Shatin, China Hong Kong Special Administrative Region.
David Sc HuiDepartment of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, China Hong Kong Special Administrative Region; Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, China Hong Kong Special Administrative Region.
Paul Ks ChanDepartment of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, 1/F, Clinical Sciences Building, Prince of Wales Hospital, 30-32 Ngan Shing Street, N.T., Shatin, China Hong Kong Special Administrative Region; Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, China Hong Kong Special Administrative Region. Electronic address: paulkschan@cuhk.edu.hk.
Chinese University of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19PneumoniaAdenosine MonophosphateAlanineAntiviral AgentsCOVID-19 Drug TreatmentHumansRespiratory SystemRNA, ViralSARS-CoV-2Viral LoadAdenosine MonophosphateAlanineAntiviral AgentsremdesivirRNA, ViralAnti-viralClinicalCOVID-19RemdesivirSARS-CoV-2TreatmentViral kineticsViral loadVirological

Identifiers

PMID36057383
PMCPMC9428337
OpenAlexW4293764367

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.